Liposomes containing Au coated Fe 3 O 4 referred to as magnetoplasmonic liposomes (MPL) and doxorubicin (L-Dox) are fabricated to investigate the effects of continuous and pulsed laser wavelengths on drug release from liposomes and magnetic guidance on the uptake of MPL by cancer cell line. Fluorescence microscopy was used to evaluate the apoptosis effect. A maximum temperature of about 6°C was achieved after 400 s for liposomes containing (magnetoplasmonic nanoshells) MPNSs at 100 µg/ml using 514 nm laser. Drug release of almost 100% at saturation point is obtained for MPL-DOX using 532 nm and 514 nm and about 80% and 65% in the case L-DOX for 532 nm and 514 nm lasers, respectively. For cytotoxicity measurement, one control and two treatment groups are studied. The first treatment groups are: with MPNS, with MPL, and laser irradiation. The second treatment groups are: laser hyperthermia using MPL, MPL with magnetic field (MF), MPL-DOX, and MPL-DOX with magnetic field (MF). The pulsed 532 nm laser produced higher cancer cells death i.e., lower viability in comparison to (continuous wave) CW 514 nm laser. Fluorescein isothiocyanate (FITC)-conjugated Annexin-V is used to detect cellular morphological changes at both wavelengths during the apoptosis process due to its ability of binding to phosphatidylserine at the outer surface of plasma membrane. The formulation of MPL-DOX-MF is shown to be a potential system for combined magnetically guided photothermo-chemotherapy of cancer.